In a move that contradicted the advice of a panel of outside experts, the Food and Drug Administration will not consider approving the diet pill Contrave without a large study to determine its heart risks.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/02/01/133398572/fda-rejects-diet-pill-casting-pall-over-future-of-weight-loss-medicines?ft=1&f=103537970
Posted
Feb 01 2011, 06:25 AM
by
NPR Blogs: Shots - Health News Blog